Abstract
Critical illness is a pathophysiological stress response that typically requires mechanical ventilation and hemodynamic support in an intensive care unit (ICU). Allostatic mechanisms tailor the critically ill state and eventually downregulate the stress response. Failure to downregulate the stress response can lead to increased morbidity and mortality. In general, ICU care focuses on component organ system physiology and prioritizes cardiopulmonary function. However, vast knowledge gaps exist in understanding why some patients simply fail to recover from a prolonged critical illness condition. In this review, we present an integrative physiology approach to the metabolic care in critical illness with an emphasis on skeletal allostasis. In particular, we discuss the different allostatic responses and their effects on bone in acute, prolonged, and chronic critical illness, currently available clinical interventions targeting skeletal remodeling, and emergent biological therapies with skeletal effects. It is hoped that by shifting the paradigm to a systems approach, some of the significant knowledge gaps can be closed and critical illness outcomes can be improved.
Keywords: Critical illness, metabolic bone disease, integrative physiology, allostasis, biological therapies
Current Drug Therapy
Title: Pharmacological and Biological Therapies for Metabolic Bone Disease in Critical Illness: An Integrative Physiology Approach
Volume: 5 Issue: 1
Author(s): Aaron J. Weiss, Mone Zaidi and Jeffrey I. Mechanick
Affiliation:
Keywords: Critical illness, metabolic bone disease, integrative physiology, allostasis, biological therapies
Abstract: Critical illness is a pathophysiological stress response that typically requires mechanical ventilation and hemodynamic support in an intensive care unit (ICU). Allostatic mechanisms tailor the critically ill state and eventually downregulate the stress response. Failure to downregulate the stress response can lead to increased morbidity and mortality. In general, ICU care focuses on component organ system physiology and prioritizes cardiopulmonary function. However, vast knowledge gaps exist in understanding why some patients simply fail to recover from a prolonged critical illness condition. In this review, we present an integrative physiology approach to the metabolic care in critical illness with an emphasis on skeletal allostasis. In particular, we discuss the different allostatic responses and their effects on bone in acute, prolonged, and chronic critical illness, currently available clinical interventions targeting skeletal remodeling, and emergent biological therapies with skeletal effects. It is hoped that by shifting the paradigm to a systems approach, some of the significant knowledge gaps can be closed and critical illness outcomes can be improved.
Export Options
About this article
Cite this article as:
Weiss J. Aaron, Zaidi Mone and Mechanick I. Jeffrey, Pharmacological and Biological Therapies for Metabolic Bone Disease in Critical Illness: An Integrative Physiology Approach, Current Drug Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/1574885511005010048
DOI https://dx.doi.org/10.2174/1574885511005010048 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiac ATP-Sensitive Potassium Channels: A Potential Target for an Anti-Ischaemic Pharmacological Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Therapeutic Targets for Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition
Reviews on Recent Clinical Trials Advances in Catheter Ablation: Atrial Fibrillation Ablation in Patients With Mitral Mechanical Prosthetic Valve
Current Cardiology Reviews The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Current Drug Targets Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design The Glial Sodium-Calcium Exchanger: A New Target for Nitric Oxide- Mediated Cellular Toxicity
Current Protein & Peptide Science New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design The Potential Dual Effects of Anesthetic Isoflurane on Aβ-Induced Apoptosis
Current Alzheimer Research Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
Current Pharmaceutical Design Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and Therapy
Current Pharmaceutical Design Tissue Factor and Hypertension
Current Hypertension Reviews Ca2+ Fluxes Involvement in Gene Expression During Cardiac Hypertrophy
Current Vascular Pharmacology Exercise-induced Physiological Hypertrophy: Insights from Genomics
Current Genomics N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain
Current Pharmaceutical Design Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling
Current Pharmaceutical Design Many Drugs and Phytochemicals Can Be Activated to Biological Reactive Intermediates
Current Drug Metabolism